EGFR and non-small cell lung carcinoma: The identification of factors which predict patient response is important for both clinical and economic reasons [6–8], and is especially relevant for East Asian populations where the incidence of EGFR-mutated NSCLC is at least 4-fold higher than among non-East Asian populations [9].